Here are three stocks that Wall Street thinks will skyrocket 50% or more. Ionis Pharmaceuticals (NASDAQ: IONS) has been a big loser so far this year with shares sinking 34%. The average price target for Ionis reflects a 56% premium above the current share price.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting